Croda International (LON:CRDA) Hits New 1-Year Low After Insider Selling

Shares of Croda International Plc (LON:CRDA) reached a new 52-week low on Tuesday after an insider sold shares in the company. The stock traded as low as GBX 2,567 ($32.80) and last traded at GBX 2,613.63 ($33.40), with a volume of 800317 shares traded. The stock had previously closed at GBX 2,754 ($35.19).

Specifically, insider Tom Brophy sold 380 shares of the stock in a transaction dated Monday, April 7th. The stock was sold at an average price of GBX 2,643 ($33.77), for a total value of £10,043.40 ($12,833.38).

Croda International Trading Down 1.6 %

The firm has a market capitalization of £3.69 billion, a P/E ratio of 22.70, a P/E/G ratio of 1.40 and a beta of 0.74. The company has a current ratio of 2.72, a quick ratio of 2.25 and a debt-to-equity ratio of 30.90. The stock has a 50 day simple moving average of GBX 3,059.10 and a 200-day simple moving average of GBX 3,402.88.

Croda International (LON:CRDA) last announced its earnings results on Tuesday, February 25th. The company reported GBX 142.60 ($1.82) earnings per share (EPS) for the quarter. Croda International had a net margin of 9.98% and a return on equity of 6.96%. On average, equities research analysts forecast that Croda International Plc will post 181.8307268 EPS for the current fiscal year.

Croda International Increases Dividend

The business also recently disclosed a dividend, which will be paid on Wednesday, May 28th. Stockholders of record on Thursday, April 10th will be paid a GBX 63 ($0.81) dividend. This represents a dividend yield of 2.03%. This is a positive change from Croda International’s previous dividend of $47.00. The ex-dividend date is Thursday, April 10th. Croda International’s dividend payout ratio is 93.66%.

Croda International Company Profile

Founded in 1925 with the aim of turning bio-based raw materials into innovative ingredients, Croda International is a speciality chemicals company focused on consumer care and life sciences markets. The company is focused on creating, making and selling innovative ingredients that deliver real benefits to a diverse range of customers and employs more than 6,000 people around the world.